Precision Optics Corporation (POCI) Cash from Financing Activities (2011 - 2026)
Precision Optics Corporation's (POCI) quarterly Cash from Financing Activities came in at $10.5 million in Q1 2026, up 143.66% year-on-year from $4.3 million in Q1 2025, and up 6719.76% on a QoQ basis from -$158198.0 in Q4 2025.
Precision Optics Corporation (POCI) Cash from Financing Activities (2011 - 2026) Analysis & Trends
Precision Optics Corporation (POCI) has 16 years of Cash from Financing Activities data on file, last reported at $10.5 million in Q1 2026.
- On a quarterly basis, Cash from Financing Activities rose 143.66% year-over-year to $10.5 million in Q1 2026; TTM through Mar 2026 was $10.0 million, a 74.86% increase from a year earlier, with the FY2025 full-year figure at $5.1 million, up 1028.44% from the prior year.
- Cash from Financing Activities for Q1 2026 stood at $10.5 million, up from -$158198.0 in the prior quarter.
- Over the last five years, Cash from Financing Activities for POCI reached as high as $10.5 million in Q1 2026 and fell as low as -$269019.0 in Q2 2022.
- Historically, Cash from Financing Activities has averaged $1.1 million across 5 years, with a median of -$101097.0 in 2022.
- Across the five-year window, Cash from Financing Activities plunged 374.57% in 2023 and soared 1531.07% in 2025, its largest moves.
- Year by year, Cash from Financing Activities stood at -$101097.0 in 2022, then slumped by 34.86% to -$136336.0 in 2023, then jumped by 390.21% to $395664.0 in 2024, then plunged by 139.98% to -$158198.0 in 2025, then surged by 6719.76% to $10.5 million in 2026.
- Per Business Quant data, the three most recent Cash from Financing Activities figures were $10.5 million in Q1 2026, -$158198.0 in Q4 2025, and -$158068.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | -133.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | -287.90 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | -414.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | -13.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | -255.24 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | -164.80 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | -75.80 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | -50.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | -48.13 Mn |
| 10 | Precision Optics Corporation | 33.52 Mn | 22.84 Mn | 2.06 Mn | 10.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.47 Mn |
| Mar 31, 2026 | 10.47 Mn |
| Dec 31, 2025 | -158,198.00 |
| Dec 31, 2025 | -158,198.00 |
| Sep 30, 2025 | -158,068.00 |
| Sep 30, 2025 | -158,068.00 |
| Jun 30, 2025 | -121,267.00 |
| Jun 30, 2025 | -121,267.00 |
| Mar 31, 2025 | 4.30 Mn |
| Mar 31, 2025 | 4.30 Mn |
| Dec 31, 2024 | 395,664.00 |
| Dec 31, 2024 | 395,664.00 |
| Sep 30, 2024 | 577,015.00 |
| Sep 30, 2024 | 577,015.00 |
| Jun 30, 2024 | 468,030.00 |
| Jun 30, 2024 | 468,030.00 |
| Mar 31, 2024 | 263,503.00 |
| Mar 31, 2024 | 263,503.00 |
| Dec 31, 2023 | -136,336.00 |
| Dec 31, 2023 | -136,336.00 |